Home About Opioid Dependence SUBOXONE(R) Film Friends and Family Resources Here to Help(R) Program
evolving treatment empowering patients
SUBOXONE Film: What Patients Are Saying

Listen to patients share, in their own words, how treatment with SUBOXONE Film has helped them work to manage their disease.

Amber
Andrew

This site makes use of the latest version of the Macromedia Flash Player. Download the player now!

Privacy Policy

  1. What this Privacy Policy Covers
  2. Personally Identifiable Information
  3. Children's Privacy
  4. Linked Sites
  5. Non Personally Identifiable Information Collected Automatically
  6. Information We May Place Automatically on your Computer's Hard Drive
  7. How your Information is Protected
  8. Who to Contact
  9. How you can update or change your Information
  10. Revisions to this Privacy Policy
  1. What this Privacy Policy Covers
  2. Reckitt Benckiser Pharmaceuticals Inc. ("Reckitt Benckiser") respects the privacy of every individual who visits our sites or responds to our interactive advertisements. This Privacy Policy outlines the information Reckitt Benckiser will collect and how we will use that information. This Policy will also instruct you on what to do if you do not want your personal information collected or shared when you visit Reckitt Benckiser sites or respond to our advertisements.

Back to Top

  1. Personally Identifiable Information
  2. Reckitt Benckiser will not collect any personally identifiable information about you (that is, your name, address, telephone number, or email address) unless you provide it to us voluntarily. For example, and not by limitation, we may collect personally identifiable information when you make a purchase, participate in a contest or sweepstakes promotion; fill out a questionnaire; sign up for a survey or otherwise interact with us.

    When you provide personally identifiable information to us, we may ask if you want to receive future communication from us, such as newsletters, email or other information. You can choose not to receive this communication, if you wish and you may opt-out by clicking on the link on the bottom of an email you received or by clicking here.

    If you do not want your personally identifiable information collected, please do not submit it to us. If you have already submitted this information and would like for us to remove it from our records, please click here to provide us with the email address.

    In addition to providing you with the service or information you request on our site, your personally identifiable information may also be used to help us track the way you use our site and our products. We may also combine the information you provide with information that we collect separately, including information you have provided to other organizations as well as public information. All of this will help us, for instance, better design our products, web sites and advertisements. In order to do this, we may also share your information with companies who carry out work for us. Information may be shared with service providers who provide services for or administer activities on behalf of Reckitt Benckiser (such as, but not limited to, authorization of credit card and check transactions, sweepstakes, promotions and contests). Information you submit to one or more of the Reckitt Benckiser brands may be shared with another of the Reckitt Benckiser brands. Your personally identifiable information may also be shared with service providers who warehouse product, perform order fulfillment or provide hosting services. These companies have agreed to only use your information in the way we tell them and to have procedures in place to protect the information.

    In the event a division or Reckitt Benckiser, or its assets, is bought or sold, personally identifiable information may be included among the transferred business assets.

    Reckitt Benckiser may disclose specific personally identifiable information if it determines that such disclosure is necessary to comply with the law or to protect the safety of the public. This includes exchanging personally identifiable information with other companies and organizations for fraud protection and credit risk reduction.

    If we intend to share your information with an unaffiliated company, other than as set out above, we will contact you first and give you the opportunity to remove your information from our database.

Back to Top

  1. Children's Privacy
  2. Reckitt Benckiser does not knowingly solicit or collect personally identifiable information (that is, name, address, telephone number, or email address) from individuals under the age of thirteen years. Where appropriate, Reckitt Benckiser will specifically instruct children not to submit such information on our sites or advertisements. If a child has provided us with personally identifiable information, a parent or guardian of that child should click here to provide us with the email address if they would like this information deleted from our records. Reckitt Benckiser will take all reasonable measures to delete such information from its database and to not use such information for any purpose (except where necessary to protect the safety of the child or others or as required by law).

Back to Top

  1. Linked Sites
  2. The Reckitt Benckiser web site(s) may contain links to other sites . The privacy policies at these other sites may be different from this one. You should refer to the privacy policy of any site linked to or framed within a Reckitt Benckiser site, or when you are leaving a Reckitt Benckiser site or site(s) for information and the privacy policy pertaining to that site.

Back to Top

  1. Non Personally Identifiable Information Collected Automatically
  2. In some cases, we may collect information about you that is not personally identifiable. Examples of this type of information include the type of Internet Browser you are using, the type of computer operating system you are using, and the domain name of the site from which you linked to our site or advertisement. We use this information for the purposes of better understanding our customer's interests and to help improve our business and sites.

Back to Top

  1. Information We May Place Automatically on your Computer's Hard Drive
  2. When you view one of our sites or advertisements, we may store some information on your computer. For example, this information may be in the form of a "Cookie" or similar file that will allow us to tailor a site or advertisement to better match your interests and preferences. With most Internet Browsers, you can erase Cookies from your computer hard drive, block all Cookies, or receive a warning before a Cookie is stored. Please refer to your Browser instructions or help screen to learn more about these functions. Please note that removing or blocking Cookies may interfere with your full use of our site. You may need to download applications and readjust your security settings to access some or all of the information on one or more of the Reckitt Benckiser site(s).

Back to Top

  1. How your Information is Protected
  2. Reckitt Benckiser uses industry standard security techniques to help protect against the loss, misuse or alteration of information collected from you at a Reckitt Benckiser site. When you transmit personally identifiable information, that information is stored on servers that Reckitt Benckiser has attempted to secure from unauthorized access or intrusion. Of course, the Reckitt Benckiser sites cannot be and are not responsible for unauthorized access to information by hackers who have obtained such access through illegal measures.

Back to Top

  1. Who to Contact
  2. If you have submitted personally identifiable information through a Reckitt Benckiser site or interactive advertisement, and would like that information modified, changed or deleted from our records, please click here to provide us with the email address.

Back to Top

  1. How you can update or change your Information
  2. If at any time you want to update or change your information, you may contact us by sending an email by clicking here. If have received an email and you would like to opt-out of receiving future emails, please click on the opt-out link at the bottom of that email. If you would like to be removed from our database and you have not received an email, please click here to opt-out.

Back to Top

  1. Revisions to this Privacy Policy
  2. We may modify this Privacy Policy and you should therefore periodically visit this page to be sure that you have read and agree with our most current Privacy Policy. This Privacy Policy was last revised on 8 September 2010 and is effective as of 28 September 2010.

    Copyright ©2005-2010 Reckitt Benckiser Pharmaceuticals Inc. All rights reserved.

Back to Top

Please see full Product Information and Medication Guide for SUBOXONE Film

For more about SUBOXONE Tablet, please see full Product Information and Medication Guide.

Not in treatment yet? Find a Doctor

certified to treat opioid dependence in the privacy of his or her office:


More Search Options


SUBOXONE® and Here to Help® are registered trademarks of Reckitt Benckiser Healthcare (UK) Ltd.
SUBOXONE Film is manufactured for Reckitt Benckiser Pharmaceuticals Inc.,
Richmond, VA 23235 by MonoSol Rx LLC, Warren, NJ 07059.
Copyright © 2011 Reckitt Benckiser Pharmaceuticals Inc.

Important Safety Information

SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is indicated for maintenance treatment of opioid dependence as part of a complete treatment plan to include counseling and psychosocial support. Treatment should be initiated under the direction of physicians qualified under the Drug Addiction Treatment Act.

SUBOXONE® (buprenorphine HCl/naloxone HCl dihydrate sublingual tablets) (CIII) is indicated for the treatment of opioid dependence.

SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets should not be used by patients hypersensitive to buprenorphine or naloxone.

SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets can be abused in a manner similar to other opioids, legal or illicit. Clinical monitoring appropriate to the patient’s level of stability is essential.

Chronic use of buprenorphine can cause physical dependence. A sudden or rapid decrease in dose may result in an opioid withdrawal syndrome that is typically milder than seen with full agonists and may be delayed in onset.

SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets can cause serious life-threatening respiratory depression and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other central nervous system (CNS) depressants (ie, sedatives, tranquilizers, or alcohol). It is extremely dangerous to self-administer nonprescribed benzodiazepines or other CNS depressants while taking SUBOXONE Sublingual Film or SUBOXONE Sublingual Tablets. Dose reduction of CNS depressants, SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets, or both when both are being taken should be considered.

Liver function should be monitored before and during treatment.

Death has been reported in nontolerant, nondependent individuals, especially in the presence of CNS depressants.

Children who take SUBOXONE Sublingual Film or SUBOXONE Sublingual Tablets can have severe, possibly fatal, respiratory depression. Emergency medical care is critical. Keep SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets out of the sight and reach of children.

Intravenous misuse or taking SUBOXONE Sublingual Film or SUBOXONE Sublingual Tablets before the effects of full-agonist opioids (eg, heroin, hydrocodone, methadone, morphine, oxycodone) have subsided is highly likely to cause opioid withdrawal symptoms.

Neonatal withdrawal has been reported. Use of SUBOXONE Sublingual Film or SUBOXONE Sublingual Tablets in pregnant women or during breast-feeding should only be considered if the potential benefit justifies the potential risk. Caution should be exercised when driving vehicles or operating hazardous machinery, especially during dose adjustment.

Adverse events commonly observed during clinical trials and postmarketing experience for SUBOXONE Sublingual Tablets are headache, nausea, vomiting, sweating, constipation, signs and symptoms of withdrawal, insomnia, pain, and swelling of the limbs.

Adverse events commonly observed with the sublingual administration of SUBOXONE Sublingual Film are numb mouth, sore tongue, redness of the mouth, headache, nausea, vomiting, sweating, constipation, signs and symptoms of withdrawal, insomnia, pain, swelling of the limbs, disturbance of attention, palpitations, and blurred vision.

Cytolytic hepatitis, jaundice, and allergic reactions, including anaphylactic shock, have been reported.

This is not a complete list of potential adverse events associated with SUBOXONE Sublingual Film and SUBOXONE Sublingual Tablets. Please see full Product Information for a complete list.

To report an adverse event associated with taking SUBOXONE Sublingual Film or SUBOXONE Sublingual Tablets, please call 1-877-782-6966. You are encouraged to report adverse events of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

close
close

Map Tips

Close

You are leaving Suboxone.com

Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals Inc. You are solely responsible for your interactions with such websites.

Continue Cancel

As always, the information you give us will not be sold or shared with anyone. Please see our privacy policy for more information.

This site makes use of the latest version of the Macromedia Flash Player. Download the player now!

Cancel
The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

View PDFCancel

Don't show me this message again.